S. Singhvi

Toward Optimum Benefit‐Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology Principles

K. Venkatakrishnan, M. Lehnert, Xiaofei Zhou, 2016, Clinical and translational science.